Quick answer: Evaluate a Semax source on documents, not claims: the exact sequence and formula (Met-Glu-His-Phe-Pro-Gly-Pro, C37H51N9O10S), a stated HPLC purity tied to a lot, an analytical test date, lot identifiers that match the vial, and clear storage and research-use labeling. Then verify on receipt. A listing that cannot show these is asking you to trust it, and that is not evidence. Laboratory research use only.
Sourcing is a quality-control problem
When a laboratory searches for a Semax supplier, the instinct is to compare listings. A more productive approach is to frame sourcing as incoming quality control: define what you need the material to be, decide what evidence would show that it is, and then check whether a given source supplies that evidence. Everything on this page applies to any source, and nothing on it depends on a brand name.
The article is for laboratory readers only. It does not recommend any use of the material, and it does not discuss price. It complements the where to buy Semax guide and the Semax purity testing article, and it uses the Semax product page as an example of the kind of specification that can be checked.
Step 1: define the target
Write down what the material should be before reading any listing. For Semax that is the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, molecular formula C37H51N9O10S, calculated molar mass about 813.9 g/mol, supplied as lyophilized powder. You also need a vial size that fits your planned work and a purity threshold you can defend in a methods section. If a listing gives a different sequence, a different formula or a name that blends Semax with a capped variant, stop and clarify, since the capped form is a different compound; the N-acetyl Semax amidate comparison explains the difference.
Step 2: the evidence you should be able to see
| Evidence | What it tells you | Why it is not sufficient alone |
|---|---|---|
| Sequence and formula stated | The seller knows what the compound is | A statement is not a measurement |
| HPLC purity percentage | Share of peak area for the main species | Says little about identity or counter-ions |
| Identity confirmation | Evidence the sequence matches | Method and result must be named |
| Lot or batch number | Ties documents to a vial | Must match the label you hold |
| Analytical test date | When the data were produced | Old data may not reflect current stock |
| Supplied form and storage | How the material should be kept | A claim, not a stability study |
| Research-use labeling | Intended and permitted use | Not a quality indicator |
The V8 product page lists purity as at least 98% by HPLC, the formula, the supplied form (lyophilized powder, sealed clear glass vial) and the storage conditions, and describes batch-specific documentation where published. The COA page shows how that documentation is organized. The how to read a COA and understanding HPLC purity guides explain what each element means.
Step 3: why the documents are never the whole answer
A synthetic peptide is made by stepwise solid-phase chemistry and then purified, and each step leaves characteristic impurities: truncated and deletion sequences, products of incomplete deprotection, and oxidation or racemization products [1,2]. The sustainability and process literature on peptide manufacturing describes how purification is a major part of the work, which is why a purity figure is a statement about what remained after it [3]. Oxidation is a recognized chemical instability route for protein drugs [5]. A report can therefore be accurate and still not answer your question, for example if the HPLC method does not resolve a closely related impurity, or if the figure is peak area and not peptide content by weight. Counter-ions and water mean the mass in a vial is not all peptide.
For Semax the relevant specific risks are the methionine, which can oxidize, and the Pro-Gly-Pro tail, where a deletion product would be hard to see if the method is not resolving enough. These are reasons to ask what method was used and to run your own check when the work depends on it.
Step 4: questions to ask any source
- What methods produced the purity and identity data, and on which lot?
- Does the lot identifier on the document match the one on the vial?
- When was the analysis done, and how has the material been stored since?
- Is the document specific to the lot or generic to the product?
- What does the source say about storage and handling, and is it consistent with general peptide stability practice [4]?
- Is the research-use-only labeling clear and consistent?
- Is there a way to contact the source about a specific lot?
Step 5: red flags in listings
| Pattern | Why it matters |
|---|---|
| No lot number anywhere | Documents cannot be tied to material |
| Purity stated with no method or date | Cannot be reproduced or placed in time |
| Same document for different lots | Not lot-specific |
| Identity claimed but no sequence or formula given | Cannot verify against the target |
| Human-use or benefit claims | Inconsistent with research-only status |
| Storage advice that contradicts the stated form | Signals carelessness about handling |
| Claims of guaranteed outcomes | Not a property of a chemical reagent |
No single flag is conclusive, and the absence of flags is not proof of quality. Together they help decide whether to ask more questions.
Step 6: verify on receipt
Receiving inspection is where documentation meets the real vial. Check the label against the order and the document: compound name, lot identifier, vial size. Record the appearance of the cake and any sign of damage. Move the vial to cold storage promptly and write the receipt in the storage log. If the work is quantitative, run a quick identity check (mass) and a purity check (HPLC) on a small portion, and compare with the documentation. Keep a frozen reference portion so later checks have a comparator. The storing research peptides guide covers the log, and the reconstitution calculator handles concentration arithmetic once the material is accepted.
An acceptance record template
| Field | Entry |
|---|---|
| Compound and sequence checked | Semax, Met-Glu-His-Phe-Pro-Gly-Pro |
| Formula and calculated mass | C37H51N9O10S, about 813.9 g/mol |
| Lot identifier on vial | |
| Lot identifier on document | |
| Purity as stated, method, date | |
| Identity evidence as stated | |
| Appearance on receipt | |
| Storage location and date moved | |
| Own checks performed and results | |
| Accepted or quarantined |
Quarantine is a real option. If something does not reconcile, hold the material, write down why and contact the source before using it.
Reading a purity report line by line
Suppose a report lists a main peak with a stated purity, a retention time, a test date and a lot number. Read it in this order. First, the identity of the sample: does the compound name and lot match your vial? Second, the method: is the column, gradient and detection wavelength stated, since peptide bonds absorb near 214 nm and aromatic residues near 280 nm, and a different wavelength can change the apparent purity? Third, the integration: are minor peaks listed, or only the main one? Fourth, the date: is the analysis recent relative to the stock's age? Fifth, any identity data: is a measured mass reported alongside the calculated one? A report that answers these is useful. A report with only a percentage and a logo is an assertion.
Semax contains no tryptophan or tyrosine, so it absorbs weakly at 280 nm, and detection at the peptide-bond wavelength near 214 nm is the usual choice. That is a general method point, and the report should state which wavelength was used. A report that does not state it leaves a gap: purity from one wavelength can differ from purity at another, so the number cannot be compared with a second report unless the conditions match. When you request documentation, ask for the chromatogram itself and not only the summary line, because the baseline, the minor peaks and the peak shape tell you more than the percentage does.
Comparing two documents for the same compound
When two sources offer what claims to be the same compound, a fair comparison lines up the same fields in the same order: sequence, formula, purity with method, identity evidence, lot, date and storage statement. Do not compare purity percentages in isolation, since two methods can give different numbers for the same sample. If one document has more fields filled, that is information; if one has fewer, ask for the missing ones. This is also a good moment to apply the red-flag table and to decide whether a small confirmatory analysis in your own laboratory is justified.
What this checklist cannot do
It cannot tell you that a source is good. It can only tell you whether the evidence a source provides is the kind that supports a decision, and whether your own receipt checks agree. It does not substitute for the lab's quality system, and it says nothing about use outside a laboratory. See the research library for related guides and the shop to browse available research materials.
Frequently asked questions
What should I confirm first about Semax?
Its sequence, Met-Glu-His-Phe-Pro-Gly-Pro, and formula C37H51N9O10S. Capped variants are different compounds.
Is an HPLC purity percentage enough?
No. It shows the main peak's share of peak area, not identity, counter-ion content or peptide content by weight.
Why does the lot number matter?
It ties a document to the vial you hold. Without a match, the document describes some other material.
What should I do if the documents do not match the vial?
Quarantine the material, record the discrepancy and contact the source before use.
Can I verify identity myself?
Yes, by mass spectrometry against the calculated values: average mass about 813.9 g/mol and [M+H]+ near 814.36.
What impurities are typical for synthetic peptides?
Truncated and deletion sequences, incomplete deprotection products, and oxidation or racemization products, which is why purification and method resolution matter.
What is special about Semax impurities?
The N-terminal methionine can oxidize, so an oxidized species about 16 mass units higher is the first thing to look for after storage in solution.
How should the vial be stored on arrival?
At 2–8 °C, or −20 °C for long-term storage, protected from heat, moisture and light, per the product page.
Why keep a retained reference portion?
It gives later HPLC checks a comparator from the same lot.
Is this a recommendation to use Semax for any purpose?
No. It is a laboratory quality-control guide.
Research-use statement
This product is supplied for laboratory research use only. It is not a drug, food or cosmetic, and it is not for human or animal consumption. This article describes documentation practices and does not recommend any application.
Related reading: How Semax Is Made: Solid-Phase Synthesis Explained, Semax Cognitive Function Research: Rodent Behavior Models, Semax Gene Expression in Rat Brain: Studies Compared.
References
- Palomo JM. Solid-phase peptide synthesis: an overview focused on the preparation of biologically relevant peptides. RSC Adv.. 2014;4(62):32658-32672. doi:10.1039/C4RA02458C
- Merrifield RB. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. J. Am. Chem. Soc.. 1963;85(14):2149-2154. doi:10.1021/ja00897a025
- Isidro-Llobet A, Kenworthy MN, Mukherjee S, Kopach ME, Wegner K, Gallou F, et al. Sustainability Challenges in Peptide Synthesis and Purification: From R&D to Production. The Journal of Organic Chemistry. 2019;84(8):4615-4628. doi:10.1021/acs.joc.8b03001
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of Protein Pharmaceuticals: An Update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Li S, Schöneich C, Borchardt RT. Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization. Biotech & Bioengineering. 1995;48(5):490-500. doi:10.1002/bit.260480511
